Cargando…
Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
The efficiency of conventional screening programs to identify early-stage malignancies can be limited by the low number of cancers recommended for screening as well as the high cumulative false-positive rate, and associated iatrogenic burden, resulting from repeated multimodal testing. The opportuni...
Autores principales: | Constantin, Nicolas, Sina, Abu Ali Ibn, Korbie, Darren, Trau, Matt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883983/ https://www.ncbi.nlm.nih.gov/pubmed/35225958 http://dx.doi.org/10.3390/epigenomes6010006 |
Ejemplares similares
-
Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation
por: Lu, Jennifer, et al.
Publicado: (2020) -
Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker
por: Sina, Abu Ali Ibn, et al.
Publicado: (2018) -
Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
por: Lane, R. E., et al.
Publicado: (2018) -
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
por: Sivapalan, L., et al.
Publicado: (2021) -
Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022)